Grade: GMP product Tested for sterility and bacterial endotoxins Description: HYNIC-PSMA is a PSMA-based ligand that can bind radioactive metal ions and is used as a tumor-imaging agent in prostate cancer. ⁹⁹ᵐTc-HYNIC-PSMA is a novel Technetium-99m-labeled small-molecule inhibitor of prostate-specific membrane antigen (PSMA) for the detection of prostate cancer. ⁹⁹ᵐTc-HYNIC-PSMA showed high tracer uptake (tumor-to-background ratio: 9.42 ± 2.62) in malignant lesions of prostate cancer patients. Molar weight: 567.59 g/mol (net substance) Molecular formula: C₂₄H₃₇N₇O₉ (net substance) CAS №: 2213408-17-2 Retest date: Not less than 18 months from the manufacturing date Packaging: 2R/4ml or 8R/10ml Type I glass vials with bromobutyl rubber stoppers Storage conditions: –20 ±5 °C Transportation at 2–8 °C (less than 1 month) Available quantities: 0.1 mg; 1.0 mg; custom quantity upon request